Lamivudine + Tenofovir

Find more information about this combination medication at the webpages for lamivudine

English

Approved Treatment Indication:

NA

Listen

Share

Advisory

This medicine contains a combination of 2 drugs: lamivudine and tenofovir.
Based on evidence, lamivudine and tenofovir are more effective when taken together.

Summary

What conditions lamivudine and tenofovir is used for
Lamivudine and tenofovir are used to treat HIV infection, which is a virus that attacks the immune system. They help manage the virus and prevent its progression. Tenofovir is also used to treat chronic hepatitis B, which is a liver infection caused by the hepatitis B virus. Both medicines work by reducing the viral load, which is the amount of virus in the blood, and improving the immune system's function.
How lamivudine and tenofovir works in the body
Lamivudine and tenofovir work by blocking the reverse transcriptase enzyme, which the virus needs to multiply. Lamivudine is a nucleoside reverse transcriptase inhibitor, while tenofovir is a nucleotide reverse transcriptase inhibitor. Both medicines help reduce the viral load and improve the immune system's function. By working together, they enhance each other's effects, making them a powerful combination in antiretroviral therapy.
The usual dosages and routes of administration of lamivudine and tenofovir
The usual adult daily dose for lamivudine is 300 mg, taken once a day. For tenofovir, the typical dose is 300 mg, also taken once daily. Both medicines are often combined into a single tablet for convenience. It's important to take them exactly as prescribed by a healthcare provider to ensure their effectiveness. The doses may vary based on individual health conditions and other medications being taken.
The most commonly observed adverse effects of lamivudine and tenofovir
Common side effects of lamivudine include headache, fatigue, and nausea. Tenofovir may cause nausea, diarrhea, and dizziness. Both medicines can lead to more serious side effects like liver problems and lactic acidosis, which is a buildup of lactic acid in the body. Tenofovir can also affect kidney function and bone density. It's important to monitor for these effects, especially in long-term use.
Important safety warnings and contraindications of lamivudine and tenofovir
Important warnings for lamivudine and tenofovir include the risk of lactic acidosis and severe liver problems. Tenofovir can also affect kidney function and bone health, so regular monitoring is essential. Both medicines should be used with caution in patients with existing liver or kidney issues. Contraindications include hypersensitivity to any component of the medications. Patients should be aware of the signs of lactic acidosis, such as muscle pain and difficulty breathing.

Government Approvals

US(FDA), UK(BNF)

WHO Essential Medicine

YES

Known Teratogen

No

Pharmaceutical Class

NA

Controlled Drug Substance

No

Video Thumbnail

Drug Ingredient

lamivudine + tenofovir

Summary

What conditions lamivudine and tenofovir is used for
Lamivudine and tenofovir are used to treat HIV infection, which is a virus that attacks the immune system. They help manage the virus and prevent its progression. Tenofovir is also used to treat chronic hepatitis B, which is a liver infection caused by the hepatitis B virus. Both medicines work by reducing the viral load, which is the amount of virus in the blood, and improving the immune system's function.
How lamivudine and tenofovir works in the body
Lamivudine and tenofovir work by blocking the reverse transcriptase enzyme, which the virus needs to multiply. Lamivudine is a nucleoside reverse transcriptase inhibitor, while tenofovir is a nucleotide reverse transcriptase inhibitor. Both medicines help reduce the viral load and improve the immune system's function. By working together, they enhance each other's effects, making them a powerful combination in antiretroviral therapy.
The usual dosages and routes of administration of lamivudine and tenofovir
The usual adult daily dose for lamivudine is 300 mg, taken once a day. For tenofovir, the typical dose is 300 mg, also taken once daily. Both medicines are often combined into a single tablet for convenience. It's important to take them exactly as prescribed by a healthcare provider to ensure their effectiveness. The doses may vary based on individual health conditions and other medications being taken.
The most commonly observed adverse effects of lamivudine and tenofovir
Common side effects of lamivudine include headache, fatigue, and nausea. Tenofovir may cause nausea, diarrhea, and dizziness. Both medicines can lead to more serious side effects like liver problems and lactic acidosis, which is a buildup of lactic acid in the body. Tenofovir can also affect kidney function and bone density. It's important to monitor for these effects, especially in long-term use.
Important safety warnings and contraindications of lamivudine and tenofovir
Important warnings for lamivudine and tenofovir include the risk of lactic acidosis and severe liver problems. Tenofovir can also affect kidney function and bone health, so regular monitoring is essential. Both medicines should be used with caution in patients with existing liver or kidney issues. Contraindications include hypersensitivity to any component of the medications. Patients should be aware of the signs of lactic acidosis, such as muscle pain and difficulty breathing.

Indications and Purpose

How does combination of lamivudine and tenofovir work?

Lamivudine and tenofovir work by inhibiting the replication of the HIV virus in the body. Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), which means it blocks the reverse transcriptase enzyme that the virus needs to multiply. Tenofovir is a nucleotide reverse transcriptase inhibitor, which works similarly by preventing the virus from making copies of itself. Both medicines help reduce the viral load, which is the amount of virus in the blood, and improve the immune system's function. By working together, they enhance each other's effects, making them a powerful combination in antiretroviral therapy.

How does combination of Lamivudine and Tenofovir work?

Lamivudine and Tenofovir are both antiviral medications used to treat HIV, which is a virus that attacks the immune system. They belong to a class of drugs called nucleoside reverse transcriptase inhibitors, which are medicines that block the reverse transcriptase enzyme. This enzyme is crucial for the HIV virus to multiply in the body. By blocking this enzyme, both drugs help to reduce the amount of virus in the body, which helps the immune system to function better. Lamivudine is unique because it is also used to treat hepatitis B, which is a liver infection caused by the hepatitis B virus. Tenofovir, on the other hand, is known for its long-lasting effects, which means it stays active in the body for a longer time. Both drugs are often used together in combination therapy to enhance their effectiveness in controlling HIV.

How effective is combination of lamivudine and tenofovir?

Evidence for the effectiveness of lamivudine and tenofovir comes from clinical trials and studies showing significant reductions in viral load and improvements in CD4 cell counts. Lamivudine has been proven to effectively lower HIV levels in the blood, while tenofovir is known for its strong antiviral activity and long-lasting effects. Both medicines are well-tolerated and have been shown to work well together, enhancing each other's effects. The combination is widely used in antiretroviral therapy due to its ability to maintain viral suppression and improve immune function over time.

How effective is combination of Lamivudine and Tenofovir?

Lamivudine and Tenofovir are both antiviral medications used to treat HIV, which is the virus that causes AIDS. They work by preventing the virus from multiplying in the body. Lamivudine is unique because it is also used to treat hepatitis B, which is a liver infection caused by the hepatitis B virus. It is often well-tolerated with few side effects. Tenofovir is unique in that it is also used to treat chronic hepatitis B and is known for its long-lasting effects, meaning it stays in the body longer, allowing for once-daily dosing. Both medications are nucleoside reverse transcriptase inhibitors, which means they block an enzyme the virus needs to replicate. They are often used together in combination therapy to enhance effectiveness and reduce the risk of the virus becoming resistant to treatment. This combination has been shown to effectively lower the amount of virus in the blood, improving immune function.

Directions for Use

What is the usual dose of combination of lamivudine and tenofovir?

The usual adult daily dose for lamivudine is 300 mg, taken once a day. For tenofovir, the typical dose is 300 mg, also taken once daily. Both medicines are often combined into a single tablet for convenience. It's important to take them exactly as prescribed by a healthcare provider to ensure their effectiveness. The doses may vary based on individual health conditions and other medications being taken. Patients should not adjust their dose without consulting their healthcare provider. Regular follow-ups are important to monitor the effectiveness and adjust the dose if necessary.

What is the usual dose of combination of Lamivudine and Tenofovir?

Lamivudine is usually taken as a 300 mg dose once a day for adults. It is an antiviral medication which helps to treat HIV, which is a virus that attacks the immune system. Tenofovir is typically taken as a 300 mg dose once a day as well. It is also an antiviral medication used to treat HIV and chronic hepatitis B, which is a liver infection caused by the hepatitis B virus. Both Lamivudine and Tenofovir work by stopping the virus from multiplying, which helps to control the infection. They are often used together in combination therapy to enhance their effectiveness against HIV. While they share the common goal of treating viral infections, Tenofovir has the additional use for hepatitis B, making it unique in its application.

How does one take combination of lamivudine and tenofovir?

Lamivudine and tenofovir can be taken with or without food, making them convenient for daily use. There are no specific food restrictions associated with these medications. However, it's important to take them at the same time each day to maintain consistent levels in the body. Patients should follow their healthcare provider's instructions regarding dosage and timing. If a dose is missed, it should be taken as soon as remembered, unless it's close to the time for the next dose. In that case, skip the missed dose and continue with the regular schedule.

How does one take combination of Lamivudine and Tenofovir?

Lamivudine and Tenofovir are both used to treat HIV, which is a virus that attacks the immune system. You can take both Lamivudine and Tenofovir with or without food, so it’s flexible based on your preference or routine. There are no specific food restrictions for either medicine, meaning you don’t have to avoid any particular foods while taking them. Lamivudine is unique because it also treats hepatitis B, which is a liver infection caused by the hepatitis B virus. Tenofovir, on the other hand, is known for its role in preventing HIV in people at high risk, which is called pre-exposure prophylaxis or PrEP. Both medicines work by stopping the virus from multiplying, which helps to control the infection and improve your immune system. It’s important to take them exactly as prescribed by your doctor to ensure they work effectively.

For how long is combination of lamivudine and tenofovir taken?

Lamivudine and tenofovir are typically used as part of a long-term treatment plan for managing HIV infection. The duration of use is usually lifelong, as there is currently no cure for HIV. Both medicines are taken continuously to maintain viral suppression and prevent the progression of the disease. Regular monitoring by a healthcare provider is essential to ensure the treatment remains effective and to make any necessary adjustments. Adherence to the medication regimen is crucial for achieving the best outcomes and maintaining a healthy immune system.

For how long is combination of Lamivudine and Tenofovir taken?

Lamivudine and Tenofovir are both used to treat HIV, which is a virus that attacks the immune system. The typical duration of use for both medicines is long-term, often for life, as they help control the virus but do not cure it. Lamivudine, which is also used to treat hepatitis B, works by stopping the virus from multiplying. Tenofovir, which is also used for hepatitis B, works similarly by blocking an enzyme the virus needs to reproduce. Both medicines are taken as tablets and are often part of a combination therapy, which means they are used with other HIV medicines. They share common side effects like nausea and fatigue, but each has unique side effects too. It's important to follow a healthcare provider's instructions when using these medicines to manage HIV effectively.

How long does it take for combination of lamivudine and tenofovir to work?

Lamivudine and tenofovir, when used together, typically start working within a few hours to a few days. Lamivudine, which is an antiretroviral medication, begins to reduce the viral load, which is the amount of virus in the blood, relatively quickly. Tenofovir, which is also an antiretroviral, works similarly by inhibiting the virus's ability to replicate. Both medicines share the common goal of reducing the viral load, which helps improve the immune system's function. However, the exact time it takes for noticeable effects can vary based on individual health conditions and adherence to the medication regimen.

How long does it take for combination of Lamivudine and Tenofovir to work?

The time it takes for a combination medicine to start working depends on the individual medicines involved. For example, if the combination includes ibuprofen, which is a pain reliever and anti-inflammatory drug, it typically starts working within 20 to 30 minutes. If the combination includes paracetamol, which is another pain reliever, it usually begins to work within 30 to 60 minutes. Both medicines are used to relieve pain and reduce fever, which means they share these common attributes. However, ibuprofen also reduces inflammation, which is swelling and redness, while paracetamol does not. When combined, these medicines can provide a broader range of relief, addressing both pain and inflammation more effectively. Always follow the dosage instructions provided by a healthcare professional.

Warnings and Precautions

Are there harms and risks from taking combination of lamivudine and tenofovir?

Common side effects of lamivudine include headache, fatigue, and nausea. Tenofovir may cause nausea, diarrhea, and dizziness. Both medicines can lead to more serious side effects like liver problems and lactic acidosis, which is a buildup of lactic acid in the body. Tenofovir can also affect kidney function and bone density. It's important to monitor for these effects, especially in long-term use. Both medicines share the potential for causing liver issues, so regular liver function tests are recommended. Patients should report any unusual symptoms to their healthcare provider promptly.

Are there harms and risks from taking combination of Lamivudine and Tenofovir?

Lamivudine and Tenofovir are both used to treat HIV, which is a virus that attacks the immune system. They share some common side effects, such as nausea, diarrhea, and headaches, which are discomforts in the stomach, loose stools, and pain in the head, respectively. Both drugs can also cause fatigue, which is a feeling of extreme tiredness. Lamivudine can uniquely cause symptoms like cough and nasal congestion, which is a stuffy nose. On the other hand, Tenofovir may lead to more serious effects like kidney problems and bone loss, which is a decrease in bone density. Both medications can lead to lactic acidosis, which is a buildup of lactic acid in the body that can be serious. They can also cause liver problems, which may lead to symptoms like yellowing of the skin or eyes. It's important to monitor for these effects and consult a healthcare provider if they occur.

Can I take combination of lamivudine and tenofovir with other prescription drugs?

Lamivudine and tenofovir can interact with other prescription drugs, affecting their effectiveness or increasing side effects. Tenofovir may interact with drugs that affect kidney function, such as NSAIDs, increasing the risk of kidney damage. Lamivudine can interact with other antiretrovirals, requiring dose adjustments. Both medicines can interact with drugs that affect liver enzymes, potentially altering their levels in the body. It's important for patients to inform their healthcare provider of all medications they are taking to manage potential interactions effectively. Regular monitoring of kidney and liver function is recommended to prevent adverse effects.

Can I take combination of Lamivudine and Tenofovir with other prescription drugs?

Lamivudine, which is used to treat HIV and hepatitis B, can interact with other medications that affect the kidneys, as it is processed through the kidneys. Tenofovir, which is also used for HIV and hepatitis B, shares this kidney processing pathway. Both drugs can increase the risk of kidney damage when taken with other medications that affect kidney function, such as nonsteroidal anti-inflammatory drugs (NSAIDs), which are pain relievers like ibuprofen. Unique to Lamivudine, it can interact with other antiviral drugs, potentially leading to increased side effects. Tenofovir, on the other hand, can interact with drugs that lower bone density, as it may also reduce bone mineral density. Both Lamivudine and Tenofovir should be used cautiously with other medications that affect the immune system, as they can alter the effectiveness of these drugs. It's important to consult a healthcare provider to manage these interactions effectively.

Can I take combination of lamivudine and tenofovir if I am pregnant?

Lamivudine and tenofovir are generally considered safe for use during pregnancy. They are often prescribed to prevent mother-to-child transmission of HIV. Lamivudine has a long history of use in pregnant women and is well-tolerated. Tenofovir is also used during pregnancy, but it is important to monitor kidney function due to potential effects. Both medicines are part of recommended antiretroviral regimens for pregnant women with HIV. Regular monitoring of viral load and CD4 counts is essential to ensure the health of both the mother and the baby. Healthcare providers will weigh the benefits and risks before prescribing these medications.

Can I take combination of Lamivudine and Tenofovir if I am pregnant?

Lamivudine, which is an antiviral medication used to treat HIV and hepatitis B, is generally considered safe during pregnancy. It helps prevent the virus from multiplying, reducing the risk of passing the virus to the baby. Tenofovir, which is another antiviral medication used for similar purposes, is also deemed safe for pregnant women. Both medications are often used together in combination therapy to enhance effectiveness. A unique attribute of Lamivudine is its specific use in treating hepatitis B, while Tenofovir is known for its effectiveness in treating both HIV and hepatitis B. Both medications share the common attribute of being part of antiretroviral therapy, which is a treatment that uses a combination of drugs to control HIV. They are both considered safe during pregnancy, with no significant risk of birth defects, making them important options for managing viral infections in pregnant women.

Can I take combination of lamivudine and tenofovir while breastfeeding?

Lamivudine and tenofovir are generally considered safe during breastfeeding, but there are some considerations. Lamivudine passes into breast milk in small amounts, but it is not known to harm the baby. Tenofovir also passes into breast milk, but studies have not shown adverse effects on infants. Both medicines are used to reduce the risk of HIV transmission to the baby. However, in some regions, breastfeeding is not recommended for HIV-positive mothers to prevent transmission. It's important for mothers to discuss breastfeeding with their healthcare provider to make an informed decision based on their specific situation.

Can I take combination of Lamivudine and Tenofovir while breastfeeding?

Lamivudine, which is an antiviral medication used to treat HIV and hepatitis B, is generally considered safe during breastfeeding. It passes into breast milk in small amounts, but studies have shown that it does not harm the nursing infant. Tenofovir, which is another antiviral medication used for similar purposes, also passes into breast milk in low levels. Research indicates that it is safe for breastfeeding mothers and their babies. Both Lamivudine and Tenofovir share the common attribute of being used to manage HIV and hepatitis B infections. They are both considered safe for use during breastfeeding, with minimal risk to the infant. However, it is important for mothers to consult with their healthcare provider to ensure these medications are appropriate for their specific situation. Each medication has its own unique properties, but their safety profiles during lactation are reassuring for nursing mothers.

Who should avoid taking combination of lamivudine and tenofovir?

Important warnings for lamivudine and tenofovir include the risk of lactic acidosis, which is a buildup of lactic acid in the body, and severe liver problems. Tenofovir can also affect kidney function and bone health, so regular monitoring is essential. Both medicines should be used with caution in patients with existing liver or kidney issues. Contraindications include hypersensitivity to any component of the medications. Patients should be aware of the signs of lactic acidosis, such as muscle pain and difficulty breathing, and seek medical attention if they occur. Regular follow-ups with healthcare providers are crucial to manage these risks.

Who should avoid taking combination of Lamivudine and Tenofovir?

Lamivudine and Tenofovir are both used to treat HIV, which is a virus that attacks the immune system. Both medicines can cause a serious condition called lactic acidosis, which is a buildup of lactic acid in the blood. This condition can be life-threatening and requires immediate medical attention. Lamivudine can cause liver problems, which means it can damage the liver, and it should be used with caution in people with liver disease. Tenofovir can also affect the kidneys, which are organs that filter waste from the blood, so kidney function should be monitored during treatment. Both medicines can cause a worsening of hepatitis B, which is a liver infection, if treatment is stopped suddenly. It's important to not stop taking these medicines without consulting a healthcare provider. Regular monitoring by a healthcare professional is essential to manage these risks effectively.